Cigna Group stock: Bernstein keeps USD 387.00 target for Cigna Group stock

Published on 10/23/2026 at 16:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue rose 6.70 percent to USD 71.67 billion. Cigna Group stock costs EUR 276.25 on October 23, 2026, down 1.23 percent versus Xetra close.

Analyst target and earnings

Bernstein maintained a Buy rating and a USD 387.00 target on October 5, 2026.
Cigna Group reported USD 71.67 billion in second-quarter 2026 revenue, up 6.70 percent year over year.
Cigna Group stock cost EUR 276.25 at Lang & Schwarz on October 23, 2026 at 4:39 p.m. CEST, down 1.23 percent versus the Xetra close of October 22, 2026.

Aquarellmalerei der Skyline von Hartford mit Fluss und modernen Bürotürmen in Pastellfarben — Cigna Group Aquarell-Stadtpanorama Hartford Connecticut, ISIN US1255231003, Fluss und Skyline in Pastelltönen, Illustration mit AI erstellt.

Cigna Group (ISIN US1255231003) had a USD 387.00 price target and a maintained Buy rating from Bernstein on October 5, 2026, implying 25.15 percent upside from the USD 309.22 NYSE price. According to Gekko, the target was the highest among the listed recent analyst views. Cigna Group stock was trading at EUR 276.25 at Lang & Schwarz on October 23, 2026 at 4:39 p.m. CEST, down 1.23 percent versus the Xetra close of October 22, 2026 at EUR 279.70.

Revenue growth meets a higher outlook

The second-quarter 2026 figures provide the latest operating benchmark. Cigna Group reported USD 71.67 billion in revenue, up 6.70 percent from the second quarter of 2025, while GAAP diluted earnings per share rose 10.20 percent to USD 6.29. The figures came from the quarter ended June 30, 2026 and were published on September 25, 2026 by Financial Report Insights.

The company also reported adjusted earnings per share of USD 7.78 for the quarter. In its July 30, 2026 earnings call, management raised full-year 2026 adjusted earnings per share guidance to at least USD 30.45, according to Yahoo Finance.

Price position on October 23

The primary-market quote was USD 309.22 for Cigna on October 23, 2026 at 10:52 a.m. ET, down 2.11 percent on the session. The NYSE price stood between a 52-week low of USD 239.51 and a 52-week high of USD 316.27, placing it 2.23 percent below the high. Market capitalization was USD 81.7 billion and the price-to-earnings ratio was 12.80.

What comes next for valuation

The next scheduled earnings report is November 5, 2026, before the market opens. The latest consensus cited by Gekko was USD 342.29 from 19 firms, while the Bernstein target of USD 387.00 points to a wider range of expectations. The target sits 25.15 percent above the USD 309.22 NYSE price, a calculation that separates the analyst view from the euro quotation.

Comparison with peers

Cigna Group: down 1.23 percent versus the Xetra close, P/E 12.80, market capitalization USD 81.7 billion.

UnitedHealth Group: down 0.52 percent on NYSE, P/E 24.13, market capitalization USD 379.5 billion.

Elevance Health: down 0.64 percent on NYSE, P/E 18.88, market capitalization USD 95.9 billion.

Stock stays below its yearly high

Cigna's latest quarterly revenue growth and raised adjusted earnings outlook provide the operating backdrop for the valuation discussion. The stock's euro quotation remains 2.23 percent below its 52-week high in the primary-market currency comparison, while the analyst targets remain above the latest NYSE price.

The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.